Syngenta to Address Global Agricultural Challenges at WEF, Championing AI to Empower Farmers and Create Open Technology Access
As farmers globally grapple with unprecedented economic, geopolitical, and environmental pressures; the agricultural sector faces a continued contraction. An alarming decrease in active farms worldwide and rising financial distress underscore the urgent need for innovation and technology to ensure a resilient food system.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260118646017/en/
Jeff Rowe, Syngenta Group CEO
"Farmers today are navigating one of the most complex periods in modern agriculture, facing pressures that demand urgent action and real solutions," said Jeff Rowe, CEO of Syngenta Group. "We have a critical window of opportunity to reverse troubling trends by ensuring every farmer, regardless of farm size or technical background, can access the transformative power of AI and digital tools.”
“When we combine AI and digital tools with deep agricultural expertise, we unlock genuine potential to revolutionize farming. But technology alone isn’t enough. Policymakers and businesses must work together to demonstrate how AI can deliver tangible results, simplify farming operations and dispel misconceptions that farmers must be tech experts to use and benefit from these tools. We must also work together to build strong foundations of trust – through peer validation, transparency about data usage and outcomes farmers can see and measure in their own fields.”
A recent research study conducted by IPSOS in partnership with Syngenta highlights a growing digital divide within the agricultural sector. While larger farms rapidly adopt advanced AI and digital tools, smaller and older farmers risk being left behind. The study underscores the urgent need for concerted action to ensure technological advancements. This represents not a challenge, but an invitation to make agricultural technology more widely available and unlock value to benefit all segments of the farming community.
Syngenta's Cropwise platform is already deploying powerful AI-driven solutions that empower farmers at every scale:
- Cropwise Grower GenAI Chatbot: Already empowering over 2 million farmers across India, this innovative chatbot delivers 24/7 multilingual agronomy support. Smallholders and large operators alike can simply speak or text, or take a picture of an ailing plant, to receive instant analysis, disease diagnosis, and product recommendations with 95% accuracy. This system leverages advanced Natural Language Processing (NLP) and voice recognition to handle local dialects, offering localized advice that previously required costly field visits or call centers.
- Predictive Intelligence for Pest & Disease Outbreaks (Launching soon in selected markets): This next-generation regional predictive alert system combines real-time pest and disease scouting data with advanced risk modelling and geospatial AI to forecast outbreak likelihood and geographic spread. This enables farmers to take proactive, preventative action before issues reach their fields rather than reacting after problems emerge. These innovations are designed with the aim of simplifying farming operations and making advanced agricultural insights accessible to all.
Syngenta is pioneering digital and AI equity in agriculture, serving as an ecosystem enabler committed to making digital solutions and AI affordable, aspirational, and accessible across all farmer segments. Syngenta is opening its Cropwise digital platform to third-party developers to co-innovate and tackle agriculture’s technology divide, recognizing the importance of responsible data management governed by comprehensive data governance policies. Syngenta does not give access to any individual grower data without explicit owner consent and maintains a robust compliance program aligned with applicable data protection laws and other relevant regulations.
At the World Economic Forum in January 2026, Syngenta is championing collaborative approaches and policy frameworks that support a wider access to agricultural technology and accelerate sustainable farming practices globally. On 21 January 2026, The Financial Times, in collaboration with Syngenta, is convening a roundtable on the sidelines of the World Economic Forum Annual Meeting in Davos. A select group of global business leaders, senior policymakers and leading academics will explore how AI can be applied responsibly across the food value chain and identify the pathways to transform technological potential into lasting, scalable impact.
Link to research study by IPSOS in partnership with Syngenta: https://www.syngenta.com/agriculture/agricultural-technology/artificial-intelligence/can-ai-be-agricultures-great-equalizer
About Syngenta Group
Syngenta Group is one of the world’s biggest agricultural innovation companies, employing over 56,000 people in more than 90 countries. Syngenta Group is focused on developing technologies and farming practices that empower farmers, so they can make the transformation required to feed the world’s population while preserving our planet. Syngenta Group’s bold scientific discoveries deliver better benefits for farmers and society on a bigger scale than ever before. Guided by its Sustainability Priorities, Syngenta Group supports farmers to grow healthier plants in healthier soil with a higher yield.
Syngenta Group, which is registered in Shanghai, China, and has its management headquarters in Switzerland, draws strength from its four business units: Syngenta Crop Protection, headquartered in Switzerland; Syngenta Seeds, headquartered in the United States; ADAMA®, headquartered in Israel; and Syngenta Group China.
To find out more about how our innovation is empowering farmers around the world, read our articles on the Stories section of our Syngenta Group website.
For Syngenta Group photos and videos, please visit the Syngenta Group Media Library.
Data protection is important to us. You are receiving this publication on the legal basis of Article 6 para 1 lit. f GDPR (“legitimate interest”). However, if you do not wish to receive further information about Syngenta Group, just send us a brief informal message and we will no longer process your details for this purpose. You can also find further details in our privacy statement.
Cautionary Statement Regarding Forward-Looking Statements
This document may contain forward-looking statements, which can be identified by terminology such as “expect,” “would,” “will,” “potential,” “plans,” “prospects,” “estimated,” “aiming,” “on track” and similar expressions. Such statements may be subject to risks and uncertainties that could cause the actual results to differ materially from these statements. For Syngenta Group, such risks and uncertainties include risks relating to legal proceedings, regulatory approvals, new product development, increasing competition, customer credit risk, general economic and market conditions, compliance and remediation, intellectual property rights, implementation of organizational changes, impairment of intangible assets, consumer perceptions of genetically modified crops and organisms or crop protection chemicals, climatic variations, fluctuations in exchange rates and/or grain prices, single source supply arrangements, political uncertainty, natural disasters, and breaches of data security or other disruptions of information technology. Syngenta Group assumes no obligation to update forward-looking statements to reflect actual results, changed assumptions or other factors.
© 2026 Syngenta. All rights reserved.
®/™ are Trademarks of companies belonging to the Syngenta Group.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260118646017/en/
Contacts
Contact Information
Media Relations
media@syngentagroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alta Semper Signs Definitive Agreements to Acquire a Majority Stake in Nature’s Rule, a MENA-Focused Leader in Dietary Supplements and Sports Nutrition19.1.2026 10:13:00 EET | Press release
Alta Semper, a London-based private equity firm focused on healthcare and consumer investments across growth markets, today announced that it has signed definitive agreements to acquire a majority stake in Nature’s Rule, a leading sports nutrition and dietary supplements company headquartered in the UAE, with an established manufacturing presence in Egypt. The acquisition is a majority investment in Prowell Holding, the parent company of Nature’s Rule, the operator of the largest fully dedicated sports nutrition and dietary supplements manufacturing facility in MENA. The company’s infrastructure and in-house R&D capabilities support a portfolio of private-label clients and proprietary brands, including Redrex, its flagship, market-leading sports nutrition brand developed in collaboration with global bodybuilding icon Mamdouh Elssbiay (“Big Ramy”). The founders will retain a significant stake and continue to lead the business. The partnership will execute a focused value-creation plan t
The UK Chooses Bridge Over Troubled Water as the Nation’s Favourite Song of Hope in Solidarity With Refugees19.1.2026 10:00:00 EET | Press release
Simon and Garfunkel’s Bridge Over Troubled Water has been votedas the UK’s number one #HopeHit ― as part of UK for UNHCR’s ‘Hope on Repeat’ campaign, raising awareness of the hardships facing refugees across the globe this winter. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260119165712/en/ Simon & Garfunkel's Bridge Over Troubled Water voted the UK's number one #HopeHit With 10% of the public vote, Bridge Over Troubled Water emerged as the UK’s most popular #HopeHit. Since November, the UN Refugee Agency’s national charity partner has invited people to nominate their #HopeHits - the tunes that connect us and warm our hearts as the weather gets cold. The top hit is announced today, Blue Monday, to help people get through the most depressing day of the year. The 1970 chart topper held off stiff competition from Stand By Me by Ben E King with 5.7% of the vote and Imagine by John Lennon with 5.3%. Hope on Repeat in support o
Prodalim Expands SOLOS Capabilities with New Dealcoholization Site in Spain19.1.2026 09:33:00 EET | Press release
Prodalim, a global leader in juice and specialty ingredients solutions, announced today the expansion of its SOLOS division with the opening of a dedicated dealcoholization and aroma recovery site in Valencia, Spain. The new facility is fully operational and strengthens Prodalim’s ability to support the rapidly growing no- and low-alcohol (NoLo) beverage market across Europe. During the coming months, an additional SOLOS site in California is planned to be inaugurated, further expanding overall capacity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260118626123/en/ Inauguration of the SOLOS Valencia Site for Advanced NoLo Solutions The global NoLo category continues to expand, driven by consumer demand for mindful drinking and healthier lifestyle choices. Industry forecasts estimate the NoLo global market at approximately USD 25 billion in 2025, with expected annual growth of 8–10% as the category expands across beers, win
ENHERTU ® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer19.1.2026 09:30:00 EET | Press release
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for ENHERTU® (trastuzumab deruxtecan) in combination with pertuzumab for the first-line treatment of adult patients with unresectable or metastatic HER2 positive breast cancer. ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use (CHMP). The application is based on data from the DESTINY-Breast09 phase 3 trial presentedduring a speciallate-breaking oral session at the 2025 American Society of Clinical Oncology (#ASCO25) Annual Meeting and subsequently published in The New England Journal of Medicine. In the trial, ENHERTU in combination with pertuz
KPMG Enters Strategic Relationship With Uniphore to Build AI Agents Powered by Industry-Specific Small Language Models19.1.2026 08:00:00 EET | Press release
Uniphore, the Business AI company, today announced a strategic relationship with KPMG LLP to operationalize AI agents across internal and client-facing workflows, supporting the firm’s continued effort to move from experimental AI pilots to production-grade deployment. As part of the collaboration, KPMG will work with Uniphore to build AI agents using Uniphore’s Business AI Cloud as a platform for agentic AI and fine-tuned small language models (SLMs), supporting clients across regulated industries including banking, insurance, energy and healthcare. Built on a sovereign, composable, and secure architecture, the platform integrates with KPMG’s existing enterprise systems and data environments, meeting governance and compliance requirements essential to regulated industries. This initiative reflects KPMG’s broader effort to equip its global workforce with AI-enabled delivery models, complementing its consulting expertise with AI-embedded execution inside core business processes. “We are
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom